# OnKure Therapeutics, Inc. (OKUR)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/OKUR/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -30.50M | $ -23.30M | $ 926.0K | $ 172.11M |
| 2025 | $ 0 | $ -60.94M | $ -53.11M | $ 549.0K | $ 56.18M |
| 2024 | $ 0 | $ -65.76M | $ -51.36M | $ 1.09M | $ 103.83M |
| 2023 | $ 0 | $ -18.96M | $ -27.22M | $ 674.0K | $ -101.84M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.01 |
| Liabilities / Eq | 0.04 |
| Current Ratio | 26.75 |

## Other views

- [Metrics](https://sponda.capital/en/OKUR.md)
- [Charts](https://sponda.capital/en/OKUR/charts.md)
- [Compare](https://sponda.capital/en/OKUR/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-29.